Galectin Therapeutics Inc (GALT)
0.8972
-0.13
(-12.89%)
USD |
NASDAQ |
Dec 23, 15:12
Galectin Therapeutics Market Cap: 56.31M for Dec. 23, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Alaunos Therapeutics Inc | 3.091M |
SELLAS Life Sciences Group Inc | 64.75M |
Oragenics Inc | 4.360M |
Anavex Life Sciences Corp | 963.28M |
Phathom Pharmaceuticals Inc | 503.94M |
Market Cap Related Metrics
Price | 0.8972 |
Earnings Yield | -81.36% |